DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Abergel A, Hezode C, Asselah T. et al.
High Efficacy and Safety of the Combination HCV Regimen Elbasvir and Grazoprevir for 8 Weeks in Treatment-Naive, Non-Severe Fibrosis HCV GT1b-Infected Patients: Final Results of the Streager Study.

Hepatology 2018;
68: 1453a-1454a

Download Bibliographical Data

Search in: